AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 295: E428-E435, 2008. First published June 3, 2008; doi:10.1152/ajpendo.90354.2008
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/E428    most recent
90354.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Perreault, L.
Right arrow Articles by Eckel, R. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perreault, L.
Right arrow Articles by Eckel, R. H.

Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?

Leigh Perreault,1 Bryan C. Bergman,1 Mary C. Playdon,1 Chiara Dalla Man,2 Claudio Cobelli,2 and Robert H. Eckel1

1Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado; and 2Department of Information Engineering, University of Padua, Padua, Italy

Submitted 10 April 2008 ; accepted in final form 29 May 2008

Our objective was to determine whether defects underlying impaired fasting glucose (IFG) are maintained and additive when combined with impaired glucose tolerance (IGT) (representing a progressive form of prediabetes) or are distinct in IFG/IGT (reflecting a parallel form of prediabetes). Volunteers with IFG (n = 10), IFG/IGT (n = 14), or normal glucose tolerance (NGT; n = 15) were matched for demographics and anthropometry. Insulin secretion was assessed using the glucose step-up protocol and insulin action through the use of a two-stage hyperinsulinemic euglycemic clamp with infusion of [6,6-2H2]glucose. Modeling of insulin secretory parameters revealed similar basal ({Phi}b) but diminished dynamic ({Phi}d) components in both IFG and IFG/IGT (P = 0.05 vs. NGT for both). Basal glucose rate of appearance (Ra) was higher in IFG compared with NGT (P < 0.01) and also, surprisingly, with IFG/IGT (P < 0.04). Moreover, glucose Ra suppressed more during the low-dose insulin clamp in IFG (P < 0.01 vs. NGT, P = 0.08 vs. IFG/IGT). Insulin-stimulated glucose uptake [glucose rate of disappearance (Rd)] was similar in IFG, IFG/IGT, and NGT throughout the clamp. We conclude that nuances of β-cell dysfunction observed in IFG were also noted in IFG/IGT. A trend for additional insulin secretory defects was observed in IFG/IGT, possibly suggesting progression in β-cell failure in this group. In contrast, basal glucose Ra and its suppressability with insulin were higher in IFG, but not IFG/IGT, compared with NGT. Together, these data indicate that IFG/IGT may be a distinct prediabetic syndrome rather than progression from IFG.

insulin resistance; isotopes; clamp



Address for reprint requests and other correspondence: L. Perreault, Univ. of Colorado Health Sciences Ctr., P. O. Box 6511, MS F8106, Aurora, CO 80045 (e-mail: leigh.perreault{at}uchsc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.